Editas Medicine
(NASDAQ) EDIT
Editas Medicine Financials at a Glance
Market Cap
$227.06M
Revenue (TTM)
$40.52M
Net Income (TTM)
$160.06M
EPS (TTM)
$-1.88
P/E Ratio
-1.23
Dividend
$0.00
Beta (Volatility)
2.07 (High)
Dividend
$0.00
Beta (Volatility)
2.07 (High)
Price
$2.30
Volume
982,826.941
Open
$2.28
Price
$2.30
Volume
982,826.941
Open
$2.28
Previous Close
$2.32
Daily Range
$2.24 - $2.48
52-Week Range
$0.91 - $4.54
Dividend
$0.00
Beta (Volatility)
2.07 (High)
Price
$2.30
Volume
982,826.941
Open
$2.28
Previous Close
$2.32
Daily Range
$2.24 - $2.48
52-Week Range
$0.91 - $4.54
EDIT News
EDIT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Editas Medicine
Industry
Biotechnology
Sector
Health CareEmployees
87
CEO
Gilmore O’Neill, MD
Website
www.editasmedicine.comHeadquarters
Cambridge, MA 02141, US
EDIT Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-198%
Return on Capital
-1%
Return on Assets
-86%
Earnings Yield
-81.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$227.06M
Shares Outstanding
97.87M
Volume
982.83K
Short Interest
0.00%
Avg. Volume
1.77M
Financials (TTM)
Gross Profit
$40.52M
Operating Income
$99.34M
EBITDA
$148.61M
Operating Cash Flow
$165.24M
Capital Expenditure
$607.00K
Free Cash Flow
$165.85M
Cash & ST Invst.
$146.65M
Total Debt
$76.71M
Editas Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.74M
-19.2%
Gross Profit
$24.74M
-19.2%
Gross Margin
100.00%
N/A
Market Cap
$227.06M
N/A
Market Cap/Employee
$923.02K
N/A
Employees
246
N/A
Net Income
$5.62M
+87.6%
EBITDA
$5.28M
+84.0%
Quarterly Fundamentals
Net Cash
$69.94M
-70.2%
Accounts Receivable
$15.18M
-6.7%
Inventory
$0.00
N/A
Long Term Debt
$65.68M
+222.3%
Short Term Debt
$11.03M
-24.7%
Return on Assets
-85.81%
N/A
Return on Invested Capital
-1.19%
N/A
Free Cash Flow
$36.45M
+29.0%
Operating Cash Flow
$36.39M
+28.3%